A powerful and specialised antagonist of 5-HT3 receptors is granisetron. The drug’s antiemetic effects are produced by inhibiting 5-HT3 receptors, which are found both centrally (in the medullary chemoreceptor zone) and peripherally (GI tract). Through the direct reduction of serotonin activity in the area postrema and the chemoreceptor trigger zone, as well as indirect inhibition at the level of the area postrema, this inhibition of 5-HT3 receptors, in turn, limits the visceral afferent stimulation of the vomiting centre.
*Products will not be offered for sale in countries where valid Patents are in force.
* It is the responsibility of the buyer to comply with the above.
|API Name :||Granisetron Hydrochloride|
|CAS Number :||107007-99-8|
|Grade :||IP / BP / USP|
|Packing Type :||Drum|
|Therapeutic use :||5 - HT3 receptor antagonists|
|Product MOQ :||5 kg|